QualityStocksNewsBreaks Archives - Page 843 of 1423

ThursdayOct 29, 2020 2:16 pm

QualityStocksNewsBreaks – Cannabis Global Inc.’s (CBGL) Advanced CBD Infusion Technologies Featured in SmallCapVoice.com Interview

Cannabis Global (OTC: CBGL), a science-forward company developing CBD infusion technologies and products while investing in fast-growing segments of the cannabis industry, was featured in a new interview with SmallCapVoice.com, Inc. (“SCV”). Among other topics, CBGL CEO Arman Tabatabaei joined SCV’s Stuart Smith to discuss Cannabis Global’s HempYouCanFee(TM) product line, as well as a new partnership that provides international reach. Tabatabaei discusses several provisional patents Cannabis Global has on deck, three of which are at the forefront of its growth strategy. Describing Cannabis Global’s CBD coffee pods and other exciting innovative products, as well as its ability to create new…

ThursdayOct 29, 2020 1:56 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Secures $11.5M in Upsized Public Offering

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a Vancouver, Canada-based company focused on manufacturing pharmaceutical-grade cannabinoids via synthetic biology, has closed its previously announced upsized public offering of 17,692,307 units of the company, each at a price of $0.65, including 2,307,692 units issued pursuant to the full exercise of the over-allotment option. The company secured aggregate gross proceeds of approximately $11.5 million in the offering. Williow Biosciences expects to use net proceeds for the commercialization of cannabigerol (“CBG”) and other portfolio cannabinoids of the company, general and administrative expenses, working capital and general corporate purposes. To view the full press release,…

ThursdayOct 29, 2020 1:33 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Notes Upcoming Launch of Bidi Vapor’s Newest Smokeless Nicotine Product

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has announced the upcoming launch of the Bidi(TM) Nicotine Pouch. Kaival Brands has an exclusive partnership and distribution agreement with Bidi(TM) Vapor, the creator of the Bidi Pouch, which is designed to provide a premium smokeless nicotine experience. The pouch features a tobacco-free nicotine formulation packed into an easy-to-carry pouch. With the nicotine-pouch sector forecast to reach $3.35 billion by 2025, the potential for the new product looks to be significant. The Bidi Pouch is positioned to leverage…

ThursdayOct 29, 2020 1:16 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Conditional FDA Acceptance of Proprietary Name for Lead Drug Candidate

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has received conditional FDA acceptance of the proprietary name REQORSA(TM), its lead drug candidate for treatment of non-small cell lung cancer. The drug candidate was known previously by the laboratory designation GPX-001. The approval of the new name marks a critical branding milestone for the company. Genprex’s REQORSA (pronounced “re-KORE-suh”) immunogene therapy features the company’s exclusive ONCOPREX(TM) nanoparticle delivery system that delivers cancer-fighting genes. The name will be resubmitted to the FDA for final review and approval after all required clinical trials…

ThursdayOct 29, 2020 12:54 pm

QualityStocksNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Announces Board Appointment of Seasoned Securities Attorney

Creatd (NASDAQ: CRTD, CRTDW), the parent company of Vocal, a robust, proprietary technology platform for digital creators, today announced the appointment of LaBrena Jones Martin to its Board of Directors, where she will chair its Corporate Governance and Nomination Committee and serve on the Compensation and Audit Committees. Martin brings extensive legal experience at the senior management level, spanning nearly 40 years and encompassing all facets of corporate and securities law. “Over the years, it has been my privilege to work closely with LaBrena at Lehman and again at RBC, where we collaborated on many strategic, complex and mission-critical projects.…

ThursdayOct 29, 2020 12:33 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Addresses Continuous Disclosure Review

Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has provided an update on its efforts to resolve a continuous disclosure review that was issued earlier this year. Champignon is working closely with the British Columbia Securities Commission (“BCSC”) to coordinate the revocation of the cease trade order and hopes to provide information about a revocation of the order as soon as possible. In the update, the company noted that it has submitted all documentation requested by the BCSC in connection with the review of financial statements of AltMed Capital Corp. ("AltMed") for the period ended June 30, 2020. The purpose of the…

ThursdayOct 29, 2020 11:43 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Reports 35% Increase in Artist Sign Ups, Registrations on Fan Pass

Friendable (OTC: FDBL), a mobile technology and marketing company engaging users through its proprietary mobile and desktop applications, today announced a notable surge in activity and growth data correlated to artist sign ups or registrations on Fan Pass, the company’s live streaming artist platform. New artist registrations continue to climb following FDBL’s October 12th update, attaining 128 new artists from October 13-27, representing an increase of 35%. Fan Pass is available for download on the Apple App Store and the Google Play Stores. “As the uncertainty continues around live venues and performances, we feel even stronger demand from artists seeking…

ThursdayOct 29, 2020 11:31 am

QualityStocksNewsBreaks – Appreciated Media Holdings Inc. (TSX.V: AMH) (OTCQB: AMEFF) Enters into Debt Settlement Agreement

Appreciated Media (TSX.V: AMH) (OTCQB: AMEFF) has announced a debt settlement agreement. According to the agreement, AMEFF will settle $120,000 of debt by issuing for sale units of the corporation. The agreement, which is subject to the approval of the TSX Venture Exchange, notes that Appreciated Media will issue 923,077 units at a sales price of $0.13 per unit. Each unit represents one common share in the capital of Appreciated Media Holdings and gives the holder rights acquire one additional common share at an exercise price of $0.25 per share any time for one year from the date of issuance.…

ThursdayOct 29, 2020 10:44 am

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Announces 60% Acquisition of Leading iPad Solution for Auto Dealers, Drivers

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA), a leader in online vehicle transactions using smartphones, has announced that it has added IntellaCar to its virtual transaction platform. PBX made the addition by signing a membership interest purchase agreement through its subsidiary DRIVRZ US LLC. ("DRIVRZ US") to acquire 60% of IntellaCar, a leading iPad solution for automotive dealers and drivers. The agreement outlines plans for DRIVRZ to pay $1.5 million in cash, along with 2 million common shares of PBX, for the transaction. The total purchase price, which was negotiated at arm's length and is based on an issuance…

ThursdayOct 29, 2020 9:00 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Completion of Drug for Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has through its European manufacturer, BSP Pharmaceuticals S.p.A. ("BSP"), finished manufacturing its lead drug candidate for upcoming Phase 2 clinical trials. Berubicin is CNSP’s lead drug candidate for the treatment of glioblastoma multiforme (“GBM”), an aggressive form of brain cancer that is incurable. With the completion of the manufacturing, CNS Pharmaceuticals is now ready to kick off its planned Phase 2 clinical trials and file an Investigational New Drug Application ("IND"). CNSP contracted with two manufacturers…

Site Search

Company Search

Category: QualityStocksNewsBreaks